I thought I'd check out your other investments. I only get 1 post per day on CYDY.
However, often times I am surprised that a poster makes a perfectly rational post on one penny stock board, but then is sucked in by another.
I spent about 3 minutes investigating this stock before noticing they are attached to Aegis Capital, who is a known toxic spiral finance company.
Any company using them WILL tank, and I notice this one is falling. If they are in any way legit, they will have to do a reverse split to get the share price back above $5, them's just the facts.
You state you've never shorted a stock. Me neither. Although I've seen so many stocks I should be. ALL stocks tend to drop twice as quickly as they rise, but I would rather stay conservative.
Why not invest in real companies with real earnings? I made 16% in SMCI just last week! There is so much money to be made right now in the stock market and you're attaching yourself to this anchor?
However, often times I am surprised that a poster makes a perfectly rational post on one penny stock board, but then is sucked in by another.
I spent about 3 minutes investigating this stock before noticing they are attached to Aegis Capital, who is a known toxic spiral finance company.
Any company using them WILL tank, and I notice this one is falling. If they are in any way legit, they will have to do a reverse split to get the share price back above $5, them's just the facts.
You state you've never shorted a stock. Me neither. Although I've seen so many stocks I should be. ALL stocks tend to drop twice as quickly as they rise, but I would rather stay conservative.
Why not invest in real companies with real earnings? I made 16% in SMCI just last week! There is so much money to be made right now in the stock market and you're attaching yourself to this anchor?
Just my opinion, of course.
Recent RNXT News
- RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/16/2026 09:10:26 PM
- Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 04/09/2026 02:19:11 PM
- RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum • GlobeNewswire Inc. • 04/08/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 12:00:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 12:00:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 12:00:02 AM
- RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026 • GlobeNewswire Inc. • 04/01/2026 06:20:16 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/31/2026 08:19:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:38:46 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:34:03 PM
- RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/30/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 11:00:10 AM
- RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment • GlobeNewswire Inc. • 03/26/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 01:16:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 01:16:41 AM
- RenovoRx Announces Closing of Oversubscribed $10 Million at Market Private Placement • GlobeNewswire Inc. • 03/23/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 11:00:38 AM
- RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30th at 4:30 p.m. ET • GlobeNewswire Inc. • 03/20/2026 12:30:00 PM
- RenovoRx Announces $10 Million at Market Private Placement • GlobeNewswire Inc. • 03/18/2026 12:35:18 PM
- RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum • GlobeNewswire Inc. • 02/27/2026 01:30:00 PM
- RenovoRx Announces Acceptance of Clinical Data Abstract at 2026 Society of Interventional Radiology Annual Scientific Meeting • GlobeNewswire Inc. • 02/26/2026 01:30:00 PM
- RenovoRx Establishes RenovoCath® Medical Advisory Board • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2026 12:00:43 PM
